Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

5-methylpyrazole-3-carboxylic acid

Known as: 3-methylpyrazole-5-carboxylic acid 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1979
1979
Because the presence of an elevated plasma free fatty acid (FFA) concentration is not always sufficient to promote ketogenesis… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
1968
1968
Inhibition of epinephrine-stimulated lipolysis in vitro by U-19425 and nicotinic acid at concentrations of 10 -6 , 10 -5 and 10… Expand
1968
1968
Abstract The antilipemic effects of nicotinic acid (NA) and 3-methylpyrazole-5-carboxylic acid (MPC) were compared in vivo and in… Expand
1967
1967
5-Methylpyrazole-3-carboxylic acid is completely absorbed and rapidly excreted in the rat, dog, and human. After 1- or 9-mg./Kg… Expand
1967
1967
5-Methylpyrazole-3-carboxylic acid stimulated the incorporation of labeled glucose into adipose tissue in vivo without… Expand
1967
1967
5-Methylpyrazole-3-carboxylic acid in concentrations between 10-8 and 10-6 M inhibited the glycerol release of adipose tissue of… Expand
1967
1967
Summary After 4 days of treatment with U-19425, rats no longer respond to the drug with a decrease in plasma FFA and blood sugar… Expand
  • figure 1
  • table 11
Highly Cited
1967
Highly Cited
1967
Abstract 1. 1. Both lipolytic hormones (ACTH, epinephrine, glucagon) and ouabain were found to stimulate the uptake of glucose… Expand
Highly Cited
1965
Highly Cited
1965
As a hypoglycemic agent, 5-methylpyrazole-3-carboxylic acid was found to be 116 times more potent orally than tolbutamide in… Expand